
Pharmaron’s 9th Symposium: Synthetic and Medicinal Chemistry
On September 21 2019, Pharmaron is holding its ninth annual symposium: Synthetic and Medicinal Chemistry. The symposium is an opportunity for our scientists and partners to learn from world-class researchers from both industry and academia. The esteemed group of presenters will discuss the latest advancements in synthetic and medicinal chemistry. The goal of this symposium is to spark innovation, as that is the foundation to Pharmaron’s continued success.
Symposium Speakers:
- Dr. Kevin Campos, MSD, USA
Innovations in Synthetic Chemistry at MSD: Striving for the Ideal Commercial Manufacturing Process - Dr. Werngard Czechtizky, AstraZeneca, Sweden
Leveraging New Modalities for Respiratory: The Exciting Chemical Space between Small Molecules & Antibodies - Prof. Francois Diederich, ETH Zurich, Switzerland
Molecular Recognition in Chemical and Biological Systems: Chemical Models and Biostructural Investigations - Dr. Michael Hahn, Bayer AG, Germany
Discovery of a Novel Oral NO- and Heme-Independent sGC Activator BAY 1101042 - Dr. Bayard R. Huck, Merck KGaA, Germany
It’s a Small-Molecule World: Medicinal Chemistry Challenges and Opportunities for the Next Decade - Prof. Guosheng Liu, Shanghai Institute of Organic Chemistry, China
Copper-Catalyzed Radical Relay for Asymmetric C-H Functionalization - Prof. David MacMillan, Princeton University, USA
New Photoredox Reactions for Medicinal Chemistry and Biological - Dr. Jan Willem Thuring, Janssen Pharmaceutica Research & Development, Belgium
Discovery of JNJ-64619178 as a Potent and Selective PRMT5 Inhibitor for the Treatment of Lung and Hematologic Cancers